Factors influencing the acceptability of automated insulin delivery systems in youths with type 1 diabetes and their parents

IF 6.1 3区医学 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes research and clinical practice Pub Date : 2025-01-01 DOI:10.1016/j.diabres.2024.111962

Roberto Franceschi , Riccardo Pertile , Marco Marigliano , Enza Mozzillo , Claudio Maffeis , Silvana Zaffani , Carlotta Dusini , Annalisa Antonelli , Giulio Maltoni , Francesca Di Candia , Erika Cantarelli , Nicola Minuto , Marta Bassi , Ivana Rabbone , Silvia Savastio , Stefano Passanisi , Fortunato Lombardo , Valentino Cherubini , Maria Alessandra Saltarelli , Stefano Tumini

{"title":"Factors influencing the acceptability of automated insulin delivery systems in youths with type 1 diabetes and their parents","authors":"Roberto Franceschi , Riccardo Pertile , Marco Marigliano , Enza Mozzillo , Claudio Maffeis , Silvana Zaffani , Carlotta Dusini , Annalisa Antonelli , Giulio Maltoni , Francesca Di Candia , Erika Cantarelli , Nicola Minuto , Marta Bassi , Ivana Rabbone , Silvia Savastio , Stefano Passanisi , Fortunato Lombardo , Valentino Cherubini , Maria Alessandra Saltarelli , Stefano Tumini","doi":"10.1016/j.diabres.2024.111962","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>New technology has been reported as a factor driving people to choose an automatic insulin delivery system (AIDs) and to sustain its acceptance. We aimed to explore the role of continuous glucose monitoring (CGM) technology (instant scanning vs. real-time) and insulin treatment modality to determine the future acceptance of AIDs among T1D individuals.</div></div><div><h3>Methods</h3><div>239 consecutively enrolled T1D youth and their parents returned the AP questionnaire. All individuals were on CGM, using multiple daily injections (MDI) or sensor-augmented pump (SAP) therapy.</div></div><div><h3>Results</h3><div>The AP-acceptance was more than neutral, with mean overall scores of 3.91 ± 0.47 and 3.99 ± 0.43 (p = 0.07), youths and parents, respectively. Domains’ analysis revealed high scores in intention to use, usefulness, and trust in AIDs, with favorable expected judgments by others. The items with the highest overall mean scores revealed high glucose control and QoL benefits; the main hassle was the size and discomfort of wearing two devices. Multivariate analysis found that male gender and SAP therapy were associated with a higher AP-acceptance overall score (p = 0.045, 0.015, 0.0001, respectively).</div></div><div><h3>Conclusions</h3><div>Participants receiving SAP therapy demonstrated higher expectations and optimistic views about AIDs. This treatment modality can act as a trampoline to AIDs despite individuals’ glucose control and diabetes history.</div></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":"219 ","pages":"Article 111962"},"PeriodicalIF":6.1000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822724008726","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Aims

New technology has been reported as a factor driving people to choose an automatic insulin delivery system (AIDs) and to sustain its acceptance. We aimed to explore the role of continuous glucose monitoring (CGM) technology (instant scanning vs. real-time) and insulin treatment modality to determine the future acceptance of AIDs among T1D individuals.

Methods

239 consecutively enrolled T1D youth and their parents returned the AP questionnaire. All individuals were on CGM, using multiple daily injections (MDI) or sensor-augmented pump (SAP) therapy.

Results

The AP-acceptance was more than neutral, with mean overall scores of 3.91 ± 0.47 and 3.99 ± 0.43 (p = 0.07), youths and parents, respectively. Domains’ analysis revealed high scores in intention to use, usefulness, and trust in AIDs, with favorable expected judgments by others. The items with the highest overall mean scores revealed high glucose control and QoL benefits; the main hassle was the size and discomfort of wearing two devices. Multivariate analysis found that male gender and SAP therapy were associated with a higher AP-acceptance overall score (p = 0.045, 0.015, 0.0001, respectively).

Conclusions

Participants receiving SAP therapy demonstrated higher expectations and optimistic views about AIDs. This treatment modality can act as a trampoline to AIDs despite individuals’ glucose control and diabetes history.

Abstract Image

查看原文本刊更多论文

影响1型糖尿病青少年及其父母自动胰岛素输送系统可接受性的因素

目的：据报道，新技术是促使人们选择自动胰岛素输送系统（AIDs）并维持其接受度的一个因素。我们的目的是探讨连续血糖监测（CGM）技术（即时扫描与实时）和胰岛素治疗方式在确定T1D患者未来接受艾滋病的作用。方法：239名连续入组的T1D青少年及其父母填写AP问卷。所有患者均采用CGM，每日多次注射（MDI）或传感器增强泵（SAP）治疗。结果：青少年和家长的ap接受度均高于中性，平均总分分别为3.91 ± 0.47和3.99 ± 0.43 （p = 0.07）。domain的分析显示，在使用艾滋病的意图、有用性和对艾滋病的信任方面得分很高，他人的预期判断也很好。总体平均得分最高的项目显示出较高的血糖控制和生活质量；主要的麻烦是佩戴两个设备的尺寸和不舒服。多因素分析发现，男性性别和SAP治疗与较高的ap接受度总分相关（p = 分别为0.045、0.015和0.0001）。结论：接受SAP治疗的参与者对艾滋病表现出更高的期望和乐观的看法。尽管个人有血糖控制和糖尿病史，这种治疗方式可以作为艾滋病的蹦床。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes research and clinical practice 医学-内分泌学与代谢

CiteScore

10.30

自引率

3.90%

发文量

862

审稿时长

32 days

期刊介绍： Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.